Carr Financial Group Corp Has $357,000 Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Carr Financial Group Corp increased its position in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 5.4% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 610 shares of the healthcare conglomerate’s stock after purchasing an additional 31 shares during the quarter. Carr Financial Group Corp’s holdings in UnitedHealth Group were worth $357,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of UNH. Kathleen S. Wright Associates Inc. bought a new position in UnitedHealth Group during the third quarter worth about $27,000. Global Wealth Strategies & Associates boosted its stake in UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after buying an additional 32 shares in the last quarter. Macroview Investment Management LLC raised its stake in UnitedHealth Group by 671.4% during the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after acquiring an additional 47 shares in the last quarter. West Financial Advisors LLC bought a new stake in shares of UnitedHealth Group in the 3rd quarter worth about $32,000. Finally, Delos Wealth Advisors LLC grew its position in UnitedHealth Group by 757.1% during the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after acquiring an additional 53 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of research reports. Stephens lowered their target price on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. Jefferies Financial Group raised UnitedHealth Group from a “hold” rating to a “buy” rating and increased their target price for the company from $481.00 to $647.00 in a research note on Wednesday, July 17th. TD Cowen upped their target price on shares of UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research note on Friday, October 18th. Truist Financial restated a “buy” rating and issued a $625.00 price objective (down previously from $640.00) on shares of UnitedHealth Group in a research report on Wednesday, October 16th. Finally, Cantor Fitzgerald boosted their target price on UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research note on Wednesday, October 16th. Four equities research analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $615.53.

View Our Latest Report on UnitedHealth Group

UnitedHealth Group Trading Up 1.7 %

Shares of NYSE:UNH opened at $615.81 on Friday. The stock has a market capitalization of $566.72 billion, a PE ratio of 40.12, a price-to-earnings-growth ratio of 1.81 and a beta of 0.58. The company’s 50-day moving average price is $581.93 and its two-hundred day moving average price is $545.03. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.88. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $619.80.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. During the same period last year, the company earned $6.56 earnings per share. The business’s revenue was up 9.2% compared to the same quarter last year. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 27.61 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be issued a $2.10 dividend. The ex-dividend date is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.36%. UnitedHealth Group’s payout ratio is 54.72%.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.